Literature DB >> 2983089

Hypothermia-inducing peptide promotes recovery of vesicular stomatitis virus from persistent animal infections.

J V Hughes, S C Doll, T C Johnson.   

Abstract

A single injection of the hypothermia-inducing neuropeptide bombesin resulted in an excellent recovery system for reisolating viruses from Swiss albino mice infected with vesicular stomatitis virus even up to 90 days after infection. The virus was recovered from a cell homogenate prepared from whole brain tissue 24 h after intracerebral injection of bombesin; brain cells were cocultivated with BHK-21 cell monolayers and then plaqued on BHK-21 cells at 31 degrees C. All of the recovered viruses were identified as vesicular stomatitis virus by antibody neutralization and peptide analyses of some of the structural proteins. However, some of the recovered viruses were altered with regard to tryptic peptide maps, temperature sensitivity, and central nervous system disease induced compared with the viruses used to initiate the infection. Most of the recovered viruses induced a similar disease when reinoculated intracerebrally into mice, characterized by hind-leg paralysis 4 to 6 days after infection. Two of the recovered viruses were lethal, however, resulting in a relatively rapid generalized wasting disease and death in 3 to 4 days.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983089      PMCID: PMC254707     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  8 in total

1.  The effects of phenylalanine on amino acid metabolism and protein synthesis in brain cells in vitro.

Authors:  J V Hughes; T C Johnson
Journal:  J Neurochem       Date:  1976-06       Impact factor: 5.372

2.  Persistent infection of L cells with vesicular stomatitis virus: evolution of virus populations.

Authors:  J S Youngner; O T Preble; E V Jones
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

3.  Alterations in peptide structure of vesicular stomatitis virus mutant and its central nervous system isolate.

Authors:  J V Hughes; T C Johnson
Journal:  J Gen Virol       Date:  1981-04       Impact factor: 3.891

4.  Bombesin-induced poikilothermy in rats.

Authors:  Y Taché; Q Pittman; M Brown
Journal:  Brain Res       Date:  1980-04-28       Impact factor: 3.252

5.  Comparison of central nervous system disease produced by wild-type and temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  S G Rabinowitz; M C Dal Canto; T C Johnson
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

6.  Bombesin:potent effects on thermoregulation in the rat.

Authors:  M Brown; J Rivier; W Vale
Journal:  Science       Date:  1977-05-27       Impact factor: 47.728

7.  Evolution of multiple genome mutations during long-term persistent infection by vesicular stomatitis virus.

Authors:  J J Holland; E A Grabau; C L Jones; B L Semler
Journal:  Cell       Date:  1979-03       Impact factor: 41.582

8.  Status spongiousus resulting from intracerebral infection of mice with temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  M C Dal Canto; S G Rabinowitz; T C Johnson
Journal:  Br J Exp Pathol       Date:  1976-06
  8 in total
  3 in total

1.  Neuropeptide-induced hypothermia and the course of central nervous system disease mediated by temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  S C Doll; T C Johnson
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

2.  Persistent Sin Nombre virus infection in the deer mouse (Peromyscus maniculatus) model: sites of replication and strand-specific expression.

Authors:  Jason Botten; Katy Mirowsky; Donna Kusewitt; Chunyan Ye; Keith Gottlieb; Joseph Prescott; Brian Hjelle
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Beta-endorphin alters a viral induced central nervous system disease in normal mice but not in nude mice.

Authors:  S C Doll; T C Johnson
Journal:  J Neuroimmunol       Date:  1989-09       Impact factor: 3.478

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.